Wednesday, November 25, 2009, 3:46am EST - Canadian Markets open in 5 hours and 44 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Savient Pharmaceuticals Inc. (SVNT)

On Nov 24: 13.25 USD   0.00 (0.00%)  
MORE ON SVNT
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Savient Pharmaceuticals Inc (NGM:SVNT) Delayed quote dataEdit
Last Trade: 13.25 USD
Trade Time: Nov 24
Change: 0.00 (0.00%)
Prev Close: 13.25
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 28.13
Day's Range: N/A - N/A
52wk Range: 3.06 - 16.62
Volume: 0
Avg Vol (3m): 1,924,320
Market Cap: 882.79M
P/E (ttm): N/A
EPS (ttm): -0.78
Div & Yield: N/A (N/A%)
Savient Pharmaceuticals Inc. (SVNT)
1d  5d  3m  6m  1y  2y  5y  max 
 Add SVNT to Portfolio   Download Data

HEADLINES
SAVIENT PHARMACEUTICALS INC Financials
EDGAR Online Financials (Fri, Nov 13)
SAVIENT PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
EDGAR Online (Mon, Nov 9)
New Star Analyst Rankings for Savient Pharmaceuticals Inc
StarMine (Thu, Nov 5)
Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
PRNewswire (Wed, Nov 4)
Q3 2009 Savient Pharmaceuticals, Inc. Earnings Release - After Market Close
CCBN (Wed, Nov 4)
Savient Pharmaceuticals to Hold Third Quarter 2009 Financial Results Conference Call on Thursday, November 5, 2009
PRNewswire (Wed, Oct 28)
SAVIENT PHARMACEUTICALS INC Files SEC form 8-K/A, Costs Associated with Exit or Disposal Activities
EDGAR Online (Thu, Oct 22)
Wedbush Morgan Biotech Analyst Sees Access To Capital Increasing Again For Small Cap Firms
Wall Street Transcript (Tue, Oct 20)
SAVIENT PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Thu, Oct 15)
Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option
PRNewswire (Thu, Oct 15)
More Headlines for SVNT...

ANALYST
EPS Est (next year) (Dec-07) : N/A
EPS Est (in 2 years) (Dec-08) : N/A
Avg Rec (current)*: 1.3
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Savient Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development, manufacture, and marketing of pharmaceutical products that target unmet medical needs.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News Canadian Indices